KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Hims & Hers Health (HIMS) Equity Average (2019 - 2025)

Hims & Hers Health's Equity Average history spans 7 years, with the latest figure at $556.0 million for Q2 2025.

  • For Q2 2025, Equity Average rose 57.4% year-over-year to $556.0 million; the TTM value through Jun 2025 reached $556.0 million, up 57.4%, while the annual FY2025 figure was $508.8 million, 23.99% up from the prior year.
  • Equity Average for Q2 2025 was $556.0 million at Hims & Hers Health, up from $513.0 million in the prior quarter.
  • Across five years, Equity Average topped out at $556.0 million in Q2 2025 and bottomed at $72.8 million in Q1 2021.
  • The 5-year median for Equity Average is $327.7 million (2022), against an average of $346.1 million.
  • The largest YoY upside for Equity Average was 354.92% in 2022 against a maximum downside of 9.73% in 2022.
  • A 5-year view of Equity Average shows it stood at $344.9 million in 2021, then dropped by 9.73% to $311.3 million in 2022, then grew by 8.01% to $336.3 million in 2023, then soared by 36.3% to $458.4 million in 2024, then grew by 21.29% to $556.0 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Equity Average are $556.0 million (Q2 2025), $513.0 million (Q1 2025), and $458.4 million (Q4 2024).